SCHEMBL5043595

SCHEMBL5043595

COC(=O)CCc1cccc(CNC(c2cc3ccccc3o2)S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 2/20 0.37
TP53 P04637 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 1/20 0.37
BCAT1 P54687 1/20 0.37
KDM4E B2RXH2 2/20 0.36
CA12 O43570 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
AGTR1 P30556 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047894 0.90 FFAR1 (0.40) MEN1KMT2AALDH1A1TP53SMN1; SMN2
SCHEMBL5043542 0.81 PTPN1 (0.47) PTPN1MEN1KMT2AALDH1A1KDM4E
SCHEMBL5048092 0.77 ALDH1A1 (0.43) MEN1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL5043600 0.75 PTGER2 (0.49) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL5050398 0.74 SIRT2 (0.42) ALDH1A1TP53SMN1; SMN2HPGDKDM4E
SCHEMBL5043619 0.73 CYP19A1 (0.58) ALDH1A1HPGDCA12CA7CA9
SCHEMBL5046520 0.70 PTPN1 (0.47) PTPN1KMT2ASMN1; SMN2CA12CA7
SCHEMBL5043194 0.70 FFAR1 (0.50) ALDH1A1MAPT
SCHEMBL5043219 0.69 TAS2R14 (0.45) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL4873552 0.67 SIRT2 (0.48) PTPN1KMT2AALDH1A1SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442702-B2 Treatment of bone disorders; carboxy derivatives PFIZER INC. (US) 2008-10-28 US disclosed
EP-1021410-B1 PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS PFIZER (US) 2006-12-27 EP disclosed
US-6498172-B1 (3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL) -PHENOXY)-ACETIC ACID OR SALT; TREATING SUCH AS OSTEOPOROSIS PFIZER INC. 2002-12-24 US disclosed
EP-1021410-A1 PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS PFIZER INC. (US) 2000-07-26 EP disclosed
WO-1999019300-A1 PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS PFIZER INC. (US) 1999-04-22 WO disclosed